FTSE Stocks in Focus: Edenville Energy, ImmuPharma, Thinksmart, Bowleven, and JTC

Edenville Energy PLC

Based in the United Kingdom, Edenville Energy PLC (LON: EDL) is into the business of the development and exploration of energy resources, specifically uranium and coal in Africa. The company’s operations can be segregated in two operating segments, namely Coal and Others. The group has three main coal deposits, namely, Namwele, Muze, and Mkomolo in the Rukwa Coal project. Lake Nyasa and Matiri North and South are other projects of the company.

EDL-Loan agreement

In order to conduct business operations smoothly, the group’s immediate requirements for working capital will be met, as the Company has entered into an agreement with a private lender for securing a non-convertible £100,000 loan. The Loan has a fixed coupon rate of 20 per cent per annum and shall be repaid on or before 25th February 2020. The Company currently has cash resources of approximately US$190,000 including the proceeds from the Loan.

EDL-Financial Highlights for H1 FY19 period ended 30th June 2019

(Source: London Stock Exchange)

The Company’s revenue increased to £151,140 for the six-month period ended 30 June 2019 from £59,310 in H1 FY18. The company incurred a loss after taxation of £888,045 for the six-month period ended 30 June 2019 as compared to a loss of £544,959 in H1 FY18. The total comprehensive loss was £887,339 for the period as compared to a loss of £387,412 in H1 FY18. The total comprehensive loss also included a gain of £706 arising from the translation of the Tanzanian subsidiary accounts from US Dollars to Sterling. The net assets amounted to £6,367,559 as on 30th June 2019.

EDL-Stock price performance

On 2nd December 2019, at 01:47 P.M GMT, while writing, Edenville Energy PLC’s share price was reported to be trading at GBX 0.027 per share, a decline of 16.92 per cent, as compared to the previous day’s closing price, which was reported to be at GBX 0.0325 per share. The market capitalisation of the company has reportedly stood at a value of GBP 1.65 million in reference to the share’s current market price. The beta of the Edenville Energy PLC’s share has been reported to be negative at 0.75. This basically implies that the volatility in the price of the company’s stock is opposite to the volatility in the movement of the comparative benchmark index.

ImmuPharma PLC

Drug discovery and development company, ImmuPharma plc (LON: IMM) is into the business of drug development, primarily based on peptide therapeutics, which helps in the treatment of serious health disorders such as autoimmune diseases. The Company has several patents, platform technologies and many drug candidates such as Lupuzor, which helps in the treatment of life-threatening auto-immune diseases. The research work of the company is mostly carried out in France.

IMM-Recent developments

Avion and ImmuPharma will develop Lupuzor™ jointly for its commercialisation in the United States, Europe and elsewhere. Lupuzor™ will be commercialised exclusively by Avion in the United States. It is important to note that, Outside of the United States, the company retains all the rights to commercialise Lupuzor™, through distribution partnerships or through direct channels.

IMM-Financial highlights for H1 FY19 period ended 30th June 2019

The company’s revenue was recorded at £11,737 in the first half of the fiscal year 2019. The company had Cash balances of £2.3 million as on 30th June 2019. The company incurred a loss of £3.9 million for the period as against £4.1 million in H1 FY18. The expenses related to Research and development stood at £1.4 million during the period as against £2.5 million in H1 FY18. The company’s Basic and diluted loss per share stood at 2.80 pence in H1 FY19 as against 2.94 pence in H1 FY18.

IMM-Stock price performance

On 2nd December 2019, at 01:53 P.M GMT, while writing, ImmuPharma plc’s share price was reported to be trading at GBX 22.22 per share, a surge of 5.80 per cent, as compared to the previous day’s closing price, which was reported to be at GBX 21.00 per share. The market capitalisation of the company has reportedly stood at a value of GBP 35.15 million in reference to the share’s current market price. The beta of the ImmuPharma plc’s share has been reported to be at 0.11. This basically implies that the volatility in the price of the company’s stock is less than the volatility in the movement of the comparative benchmark index.

Thinksmart Ltd

The financial technology company, ThinkSmart Limited (LON: TSL) is in the business of leasing and rental financing across the United Kingdom. The company operates in two segments, namely, UK and Corporate and unallocated.

TSL-Recent news

Leading digital payment solutions provider, Thinksmart Ltd, in a press release announced that its subsidiary, RentSmart, has issued formal legal proceedings against The Carphone Warehouse Ltd for losses estimated around £20 million, as a result of low volumes generated with respect to marketing and promotion of the relevant product.

TSL-Stock price performance

On 2nd December 2019, at 01:56 P.M GMT, while writing, ThinkSmart’s share price was reported to be trading at GBX 20.00 per share, up by 25 per cent, as compared to the previous day’s closing price, which was reported to be at GBX 16.00 per share. The market capitalisation of the company has reportedly stood at a value of GBP 17.04 million in reference to the share’s current market price. The beta of the ThinkSmart’s share has been reported to be at negative at 0.58. This basically implies that the volatility in the price of the company’s stock is opposite to the volatility in the movement of the comparative benchmark index.

Bowleven plc

Oil and gas company, Bowleven plc (LON: BLVN) is focused majorly in the African region where it holds key interests in exploration and development. Exploration and appraisal activities in Cameroon and Kenya are areas of focus in the African region for the company.

BLVN-Recent News

The company released unaudited results for FY19 period ended 30th June 2019.

BLVN-Financial performance

With a development plan is being worked out on an established asset (The Etinde Block) to have various monetisation options that can be used to reap the optimum return for all our stakeholders. The company’s net assets were valued at $164,123 thousand in the fiscal year 2019. The company had cash balances of $10,482 thousand in the fiscal year 2019. The company’s total comprehensive loss for the year stood at $66,567 thousand in FY19. The Company made a special dividend payment to shareholders of 15 pence per ordinary share on 8th February 2019.

BLVN-Stock price performance

On 2nd December 2019, at 01:59 P.M GMT, while writing, Bowleven plc’s share price was reported to be trading at GBX 6.40 per share, a decline of 5.88 per cent, as compared to the previous day’s closing price, which was reported to be at GBX 6.80 per share. The market capitalisation of the company has reportedly stood at a value of GBP 22.23 million in reference to the share’s current market price. The beta of the Bowleven plc’s share has been reported to be at 0.67. This basically implies that the volatility in the price of the company’s stock is less than the volatility in the movement of the comparative benchmark index.

JTC PLC

JTC PLC (LON: JTC) provides fund management, corporate management and private wealth management services to private and institutional investors. Fund Services and Corporate Services for corporate and institutional entities are covered under The Institutional Client Services Division whereas Private Wealth Services and Corporate Services provided to HNI’s, family offices are covered under Private Client Services Division. The Company has presence across Europe, Africa, the Cayman Islands and the United States.

JTC-Recent development

Erika Schraner has joined the Board as an Independent Non-Executive Director.

JTC-Stock price performance

On 2nd December 2019, at 02:02 P.M GMT, while writing, JTC plc’s share price was reported to be trading at GBX 374.00 per share, a decline of 0.26 per cent or GBX 49.40 per share, as compared to the previous day’s closing price, which was reported to be at GBX 375.00 per share. The market capitalisation of the company has reportedly stood at a value of GBP 427.76 million in reference to the share’s current market price. The company’s annual Dividend Yield has been reported to be around 0.91 per cent.

Comparative Stock Price Chart

(Source: Thomson Reuters, Stock price comparative chart for EDL, IMM, TSL, BLVN and JTC